Innovations Stem Cell Center, recently named the top U.S. stem-cell therapy provider by Life Sciences Review, offers patients a safe, standardized, and affordable alternative to unregulated overseas ...

Key opportunities in the U.S. regenerative medicine market include the rising adoption of stem cell technology and a strong ...

Hippel indicated that overall Q2 organic growth is anticipated to be consistent with Q1, with continued strength in pharma, renewed growth in China, a rebound in spatial biology, and gradual ...

Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...

Than Powell Than Powell, CBO, Longeveron On track for top-line trial results in the third quarter of 2026 from pivotal Phase ...

REDWOOD CITY, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR, the “Company”) releases the following financial results for the fiscal quarter ended September 30, 2025. Cash ...

Spherix Global Insights’ latest Special Topix™: Neurology Pipeline Opportunities 2025 (US) service captures forward-looking insights from 79 U.S. neurologists across five key neurological ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

Operator: Greetings, and welcome to the Longeveron 2025 Q3 Financial Results and Business Update Call. [Operator Instructions ...

NewcelX Ltd. (NASDAQ: NCEL) ("NewcelX" or the "Company"), a biotechnology company advancing transformative therapies for ...

ROCHESTER HILLS, Mich. - Wrangling three children with autism consumed Dana Paduchowski’s days in a chaotic swirl, her weeks ...